In vivo interactions of TGF-β and extracellular matrix
Authors:
- John R. HarperJHJohn R. Harper
- Wayne A. BorderWBWayne A. Border
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Progress in Growth Factor Research
- Vol. 4 (4) , 369-382
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney diseaseNature, 1992
- Transforming growth factor-beta in disease: the dark side of tissue repair.Journal of Clinical Investigation, 1992
- Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosisKidney International, 1991
- Cytokines in context.Journal of Cell Biology, 1991
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1Nature, 1990
- Transforming growth factor-β regulates production of proteoglycans by mesangial cellsKidney International, 1990
- Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblastsFEBS Letters, 1988
- Cell adhesion protein receptors as targets for transforming growth factor-$beta; actionCell, 1987
- Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells.Journal of Cell Biology, 1986
- Structural-functional relationships in diabetic nephropathy.Journal of Clinical Investigation, 1984